正电子放射性显像剂<sup>18</sup>F—FDG的研究进展

孙华; 杨雁; 李琳; 杨发科; 赵雷

doi:10.3760/cma.j.issn.1673-4114,2010.06.004

正电子放射性显像剂¹⁸F—FDG的研究进展

孙华 , 杨雁 , 李琳 , 杨发科 , 赵雷

文章导航 > 国际放射医学核医学杂志 > 2010, 34 > 6: (333-336,362)

引用本文:

Citation:

正电子放射性显像剂¹⁸F—FDG的研究进展

1. 昆明医学院第三附属医院云南省肿瘤医院PET/CT中心, 650018;
2. 昆明医学院第三附属医院云南省肿瘤医院药剂科, 650018

The progress of reserch on positron radioactive ¹⁸F-FDG

Center of PET/CT, the Third Affiliated Hospital of Kunming Medical College, Tumor Hospital of Yunnan Province, Kuming 650018, China

摘要: ¹⁸F-FDG是PET-CT影像诊断重要的示踪剂之一,采用亲核取代反应制备¹⁸F-FDG比亲电取代反应更优越,因此,前者取代后者将势在必行。全自动合成模块工艺对放射性药物的规模化生产以及临床上的广泛应用起到了推动作用。近年来,新技术手段在¹⁸F-FDG合成模块中的应用也引起了人们的广泛关注。作为以静脉注射方式给药的示踪剂,¹⁸F-FDG的质量控制要求严格。先进的检测手段以及药品生产和质量管理规范的实施为¹⁸F-FDG的质量控制提供了保证。对¹⁸F-FDG的代谢动力学研究发现,该示踪剂静脉注射后的代谢过程符合三室模型,为临床用药提供了依据。该文从合成原理、工艺流程、质量控制、代谢分布与临床应用等几个方面对¹⁸F-FDG的研究进展进行综述。
- 氟脱氧葡萄糖F18 /
- 质量控制 /
- 药代动力学 /
- 工艺学,制药
Abstract: As one of the most important tracer for PET-CT, the preparation of ¹⁸F-FDG by nucleophilic substitution is better than electrophilic substitution,therefore the substitution of the former for the latter is imperative. Automatic synthesis module technology has powerful function on the large-scale production of radioactive drugs and widely clinical been used. In recent years the application of new technology in ¹⁸F-FDG synthesis module is very fascinating. The requirement for quality control of ¹⁸F-FDG is tremendously strict, for which the administration way of ¹⁸F-FDG is intravenous injection. The advanced detective methods and the standardization of Good Manufacturing Practice are guarantee to ¹⁸F-FDG quality control. The researches on pharmacokinetics of ¹⁸F-FDG show that the metabolic process accords with three-compartment model after intravenous, which provides a basis for clinical medication. In this paper, we review the ¹⁸F-FDG in detail from the principle of synthesis, craft process, quality control, metabolic distribution and clinical application and so on.
- Fluorodeoxyglucose F18 /
- Quality control /
- Pharmacokinetics /
- Technology,pharmaceutical
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Ido T, Wan CN, Fowler JS, et al. Fluorination with F₂. A convenient synthesis of 2-deoxy-2-fluoro-D-glucose. J Org Chem, 1977, 42(13):2341-2342.
[2]	Coenen HH, Pike VW, Stocklin G, et al. Recommendation for a practical production of[2-¹⁸F] fluoro-2-deoxy-D-glucose. Appl Radiat Isot, 1987, 38(8):605-610.
[3]	Brodack JW, Dence CS, Kilbourn MR, et al. Robotic production of 2deoxy-2[¹⁸F]fluoro-D-glucose:a routine method of synthesis using tetrabutylammonium[¹⁸F]fluoride. Appl Radiat Isot, 1988, 39(7):699-703.
[4]	Kilbourn MR, Hood JT, Welch MJ. A simple ¹⁸O water target for ¹⁸F production. Int J Appl Radiat Isot, 1984, 35(7):599-602.
[5]	Kilbourn MR, Jerabek PA, Welch MJ. An improved[¹⁸O] water target for[¹⁸F]fluoride production. Int J Appl Radiat Isot, 1985, 36(4):327-328.
[6]	Bogni A, Pascali C, Iwata R, et al.[¹⁸F]FDG synthesis by Anatech RB-86 robotic system:Improvements and general considerations. J Radioanal NuclChem, 1998, 230(1-2):45-50.
[7]	Toorengian SA, Mulholland GK, Jewett DM, et al. Routine producJ tion of 2-deoxy-2-[¹⁸F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Nucl Med Biol, 1990, 17(3):273-279.
[8]	Kim HW, Jeong JM, Lee YS, et al. Rapid synthesis of[¹⁸F]FDG without an evaporation step using an ionic liquid. Appl Radiat Isot, 2004, 61(6):1241-1246.
[9]	Hamacher K, Hirschfelder T, Coenen HH. Electrochemical cell for separation of[¹⁸F]fluoride from irradiated ¹⁸O-water and subsequent no carrier added nucleophilic fluorination. Appl Radiat Isot, 2002, 56(3):519-523.
[10]	Chaly T, Mattacchieri R, Velez JW, et al. A large scale manual production of[¹⁸F]FDG using a synthetic unit made of sterile disposable components an.d operated by a Master Slave Manipulator. Appl Radiat Isot, 1990, 41(1):29-34.
[11]	Culbert PA, Adam M J, Hurtado ET, et al. Automated synthesis of[¹⁸F]FDG using tetrabutylammonium bicarbonate. Appl Radiat Isot, 1995, 46(9):887-891.
[12]	Alexoff DL, Russell JAG, Shiue CY, et al. Modular automation in PET tracer manufacturing:application of an autosynthesizer to the production of 2-deoxy-2-[¹⁸F]fluoro-D-glucose. Appl Radiat Isot, 1986, 37(10):1045-1061.
[13]	Mock BH, Vavrek MT, Mulholland GK. Back-to-back "One-Pot"[¹⁸F]FDG syntheses in a single Siemens-CTI chemistry process control unit. Nucl Med Biol, 1996, 23(4):497-501.
[14]	朱丽,侯丽雅,章维一.基于微流体数字化技术的微化学反应器.中国机械工程,2007,18(5):597-599.
[15]	张锦明,张书文,田嘉禾,等.影响2-¹⁸F-2-脱氢-β-D-葡萄糖合成效率因素初探.同位素,2003,16(1):30-34.
[16]	Mulholland GK. Simple rapid hydrolysis of acetyl protecting groups in the FDG synthesis using cation exchange resins. Nuel Med Biol, 1995, 22(1):19-23.
[17]	Füchtner F, Steinbach J, Mading P, et al. Basic hydrolysis of 2-[¹⁸F] fluoro-l,3,d,6-tetra-O-acetyl-D-glucose in the preparation of 2-[¹⁸F]fluoro-2-deoxy-D-glucose. Appl Radiat Isot, 1996, 47(1):61-66.
[18]	The United States Pharmacopoeia Convention. The United States Pharmacopeia. 26 th ed. 2003:808-810.
[19]	叶肇云,齐秀珍.¹⁸FDG注射液放化纯度的测定.同位素,2004,17(2):104-107.
[20]	Ma Y, Huang BX, Channing MA, et al. Quantification of Kryptofix 2.2.2 in 2-[¹⁸F]FDG and other radiopharmaceuticals by LC/MS/MS. Nucl Med Biol, 2002, 29(1):125-129.
[21]	Mock BH, Winkle W, Vavrek MT, et al. A color spot test for the detection of Kryptofix 2.2.2 in[¹⁸F]FDG preparations. Nucl Med Biol, 1997, 24(2):193-195.
[22]	张锦明,田嘉禾.¹⁸F-FDG的质量控制及方法.中华核医学杂志,2005,25(6):383-384.
[23]	Hunter GJ, Hamberg LM, Alpert NM. Simplified measurement of deoxyglucose utilization rate. J Nucl Med, 1996, 37(6):950-955.
[24]	Phelps ME, Hoffman E J, Selin C, et al. Investigation of[¹⁸F] 2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. J Nucl Med, 1978, 19(12):1311-1319.
[25]	Gallagher BM, Ansari A, Atkins H, et al. Radiopharmaceuticals XXVⅡ. ¹⁸F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo:tissue distribution and imaging studies in animals. J Nucl Med, 1977,18(10):990-996.
[26]	李彪,朱承谟.正电子放射性药物的临床应用与进展.诊断学理论与实践,2005,4(2):93-95.
[27]	陈泽龙,王楷堂,李天然,等.¹⁸F-FDG显像剂的制备及其在肿瘤诊断中的作用评价.福建医药杂志,2006,28(1):1-3.

[1]	孙华 , 杨雁 , 李琳 , 杨发科 , 赵雷 . 正电子放射性显像剂 ¹⁸F-FDG的研究进展. 国际放射医学核医学杂志, 2010, 34(6): 333-336, 362. doi: 10.3760/cma.j.issn.1673-4114.2010.06.004
[2]	王劲 , 程亮 , 唐明灯 , 庄达君 . （N-[¹⁸F]氟甲基）胆碱的合成与质量控制. 国际放射医学核医学杂志, 2014, 38(3): 171-174. doi: 10.3760/cma.j.issn.1673-4114.2014.03.008
[3]	孙琳 , 高再荣 , 张永学 . ¹⁸F-氟代脱氧葡萄糖PET-CT用于恶性肿瘤治疗疗效评估与监测. 国际放射医学核医学杂志, 2006, 30(6): 328-331.
[4]	吕慧清 , 张中民 , 吕仲虹 . ¹⁸F-氟代脱氧葡萄糖PET在恶性肿瘤适形放射治疗中的价值. 国际放射医学核医学杂志, 2006, 30(6): 335-337.
[5]	渠浩 , 王振军 , 陈大志 , 王铁 , 韩进 , 杜燕夫 , 李敏哲 . ¹⁸F-氟代脱氧葡萄糖正电子放射导向手术在结直肠癌治疗中的初步应用. 国际放射医学核医学杂志, 2006, 30(3): 145-147.
[6]	刘晓秋 , 沈秀 , 王芹 , 龙伟 , 王浩 , 周则卫 . 尼可胺在大鼠体内的药代动力学研究. 国际放射医学核医学杂志, 2013, 37(5): 265-268. doi: 10.3760/cma.j.issn.1673-4114.2013.05.003
[7]	李新平 , 王燕 , 卢国 , 李艳静 , 于雪 , 侯文彬 , 刘昌孝 . PET分子显像技术在药代动力学研究中的应用. 国际放射医学核医学杂志, 2019, 43(4): 349-355. doi: 10.3760/cma.j.issn.1673-4114.2019.04.009
[8]	贺小红 . ¹⁸F-FDG正电子显像质量保证. 国际放射医学核医学杂志, 2004, 28(5): 193-196.
[9]	涂彧 . 乳房X射线成像术的质量控制. 国际放射医学核医学杂志, 2000, 24(1): 35-38.
[10]	涂彧 . 普通X射线诊断设备的质量控制. 国际放射医学核医学杂志, 2000, 24(1): 38-43.

点击查看大图

计量

文章访问数: 1687
HTML全文浏览量: 131
PDF下载量: 3

正电子放射性显像剂¹⁸F—FDG的研究进展

1. 昆明医学院第三附属医院云南省肿瘤医院PET/CT中心, 650018;
2. 昆明医学院第三附属医院云南省肿瘤医院药剂科, 650018

收稿日期: 2010-09-21

关键词:

摘要: ¹⁸F-FDG是PET-CT影像诊断重要的示踪剂之一,采用亲核取代反应制备¹⁸F-FDG比亲电取代反应更优越,因此,前者取代后者将势在必行。全自动合成模块工艺对放射性药物的规模化生产以及临床上的广泛应用起到了推动作用。近年来,新技术手段在¹⁸F-FDG合成模块中的应用也引起了人们的广泛关注。作为以静脉注射方式给药的示踪剂,¹⁸F-FDG的质量控制要求严格。先进的检测手段以及药品生产和质量管理规范的实施为¹⁸F-FDG的质量控制提供了保证。对¹⁸F-FDG的代谢动力学研究发现,该示踪剂静脉注射后的代谢过程符合三室模型,为临床用药提供了依据。该文从合成原理、工艺流程、质量控制、代谢分布与临床应用等几个方面对¹⁸F-FDG的研究进展进行综述。